References
- Zent CS, Wu W, Bowen DA, . Addition of granulocyte-macrophage colony stimulating factor does not improve response to early treatment of high-risk chronic lymphocytic leukemia with alemtuzumab and rituximab. Leuk Lymphoma 2013;54:476–482.
- Zent CS, Call TG, Shanafelt TD, . Early treatment of high-risk chronic lymphocytic leukemia with alemtuzumab and rituximab. Cancer 2008;113:2110–2118.
- Cartron G, Zhao-Yang L, Baudard M, . Granulocyte-macrophage colony-stimulating factor potentiates rituximab in patients with relapsed follicular lymphoma: results of a phase II study. J Clin Oncol 2008;26:2725–2731.
- Ferrajoli A. Incorporating the use of GM-CSF in the treatment of chronic lymphocytic leukemia. Leuk Lymphoma 2009;50:514–516.
- Lin TS, Flinn IW, Lucas MS, . Filgrastim and alemtuzumab (Campath-1H) for refractory chronic lymphocytic leukemia. Leukemia 2005;19:1207–1210.
- Buggins AG, Mufti GJ, Salisbury J, . Peripheral blood but not tissue dendritic cells express CD52 and are depleted by treatment with alemtuzumab. Blood 2002;100:1715–1720.
- Albitar M, Do KA, Johnson MM, . Free circulating soluble CD52 as a tumor marker in chronic lymphocytic leukemia and its implication in therapy with anti-CD52 antibodies. Cancer 2004;101: 999–1008.
- Gustafson MP, Abraham RS, Lin Y, . Association of an increased frequency of CD14 HLA-DR lo/neg monocytes with decreased time to progression in chronic lymphocytic leukaemia (CLL). Br J Haematol 2012;156:674–676.
- Orsini E, Guarini A, Chiaretti S, . The circulating dendritic cell compartment in patients with chronic lymphocytic leukemia is severely defective and unable to stimulate an effective T-cell response. Cancer Res 2003;63:4497–4506.
- Beyer M, Kochanek M, Darabi K, . Reduced frequencies and suppressive function of CD4CD25hi regulatory T cells in patients with chronic lymphocytic leukemia after therapy with fludarabine. Blood 2005;106:2018–2025.
- Carlier J, Martin H, Mariame B, . Paracrine inhibition of GM-CSF signaling by human cytomegalovirus in monocytes differentiating to dendritic cells. Blood 2011;118:6783–6792.